TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and ...
The biologic drug market is projected to reach $390 billion within the next two years, 1 and the need for efficiency and speed may be outpacing the market. The advent of personalized medicine requires ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback